ORBIMED ADVISORS LLC - 12 May 2025 SCHEDULE 13D/A Report for CORVUS PHARMACEUTICALS, INC. Common stock, par value $0.0001 per share (the "Shares"). (CRVS)

Filing Manager
ORBIMED ADVISORS LLC
Reporting Manager
ORBIMED ADVISORS LLC
Security
CORVUS PHARMACEUTICALS, INC. Common stock, par value $0.0001 per share (the "Shares").
Symbol
CRVS
Shares outstanding
80,208,385 shares
Disclosed Ownership
9,785,423 shares
Ownership
12%
Form type
SCHEDULE 13D/A
Filing time
14 May 2025, 20:49:03 UTC
Date of event
12 May 2025
Previous filing
01 May 2025
Next filing
27 Jan 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"ORBIMED ADVISORS LLC disclosed 12% ownership in CORVUS PHARMACEUTICALS, INC. Common stock, par value $0.0001 per share (the "Shares"). (CRVS) on 12 May 2025."

Quick Takeaways

  • ORBIMED ADVISORS LLC filed SCHEDULE 13D/A for CORVUS PHARMACEUTICALS, INC. Common stock, par value $0.0001 per share (the "Shares"). (CRVS).
  • Disclosed ownership: 12%.
  • Date of event: 12 May 2025.

What Changed

  • Previous schedule filing date: 01 May 2025.
  • Current filing was accepted on 14 May 2025, 20:49.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ORBIMED ADVISORS LLC 12% 9,785,423 0 9,785,423 /s/ Carl L. Gordon Carl L. Gordon/Member 0001055951
ORBIMED CAPITAL GP V LLC 12% 9,785,423 0 9,785,423 /s/ Carl L. Gordon Carl L. Gordon/Member of OrbiMed Advisors LLC 0001615374

Sponsored